Answer
Patients should be tested before starting Humira (adalimumab) because hepatitis B can reactivate in chronic carriers receiving it, sometimes fatally; those testing positive should consult a physician experienced in treating hepatitis B.
Sources for this answer
- Humira 40 mg solution for injection in pre-filled pen (Great Britain)AbbVie Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 24Document updated
Sources checked